Hex image

Search Results

Found 33 results for label/Berita.

PPD Inc | Post
EU Clinical Trial Regulation: Investigational Medicinal Product Labelling

In this blog post, Gemma Puckey, senior manager of regulatory affairs, explains the impact of the European Union (EU) Clinical Trial Regulation (CTR) 536/2014, specifically Annex VI, on labelling of Investigational Medicinal Products (IMPs).

Read More
PPD Inc | Our Solutions
Global Clinical Supplies

Our team provides complete life-cycle management

Read More
PPD Inc | Post
Regulatory Insights: ‘Right First Time’ Approach to Post-Authorization Strategy

Take a look at the importance of regulatory intelligence in anticipating challenges and mitigating risks during post-approval lifecycle maintenance.

Read More
PPD Inc | What Is a CRO?
Drug Discovery and Development Process

The drug discovery and development process is long but can result in new life-saving treatments and therapeutics.

Read More
PPD Inc | Who We Are
Receiving
Read More
PPD Inc | Post
A Practical Guide For IMP Supply Chain Planning Post-Brexit

Brian Brogan, senior logistics manager, provides guidance for clinical trial supply chain requirements post-Brexit and offers some practical solutions for affected U.K.-based life science companies.

Read More
PPD Inc | Post
New European Union Regulation to Change How Clinical Trials are Conducted

PPD experts explain what is changing and how to prepare for and navigate the transition to the EU Clinical Trials Regulation (EU CTR).

Read More
PPD Inc | Our Solutions
Access Programs and Studies

Experience in the past 5 years

Read More